Neurizon Therapeutics (ASX:NUZ) Capital Expenditure : A$0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Neurizon Therapeutics Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Neurizon Therapeutics's cash flow for capital expenditures for the six months ended in Dec. 2024 was A$0.00 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.00 Mil.

Neurizon Therapeutics Capital Expenditure Historical Data

The historical data trend for Neurizon Therapeutics's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurizon Therapeutics Capital Expenditure Chart

Neurizon Therapeutics Annual Data

Trend

Jun01

Jun02

Jun03

Jun04

Jun05

Jun24

Capital Expenditure

Get a 7-Day Free Trial

-0.27

-0.37

-3.50

Neurizon Therapeutics Semi-Annual Data
	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Jun24	Dec24
Capital Expenditure	Get a 7-Day Free Trial															-0.12	-	-	-	-

Neurizon Therapeutics Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

Neurizon Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurizon Therapeutics Ltd (ASX:NUZ) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

ECQ0:Germany

Address

96-100 Albert Road, Level 4, South Melbourne, Melbourne, VIC, AUS, 3205

Website

https://www.neurizon.com

Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).

Neurizon Therapeutics Headlines

No Headlines